LGALS3 and obesity disorder: Galectin-3, another notable protein within the context of the adipose tissue secretome and autophagy, has been identified as a biomarker for metabolic syndrome and obesity, attributed to its elevated levels in the plasma of patients with obesity and type 2 diabetes [88–91].